Updates

Inspecs - Pretax profit guided to grow 22% to £9.9m

July 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Inspec’s AGM statement was poorly executed and the RNS could have been articulated far more effectively. Whilst biting my lip, I would have framed it like this: “H1 performance is in line with expectations, with an H2 weighting for FY24 and exciting growth in the UK and US pipeline. Overall profit is guided to grow 22% from £8.1m to £9.9m. Financial performance for the full year remains in line with expectations with EBITDA up from £18m to £19.5m. Encouraging start to H2 with high activity levels across the board. Own brand sales continue to perform strongly, particularly in the US. FY24 revenue growth will be weighted towards H2, reflecting strong comparatives in the order book last period; ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

DiscoverIE

ME Group

Inspecs - Large US business wins enhance H2 (October 2024)

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam (January 2024)

Inspecs (October 2023)

Inspecs (August 2023)

Inspecs - EBITDA forecast to jump US$6m this year (July 2023)

Inspecs (May 2023)

Inspecs (February 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X